Wikipedia -WSS

Wikipedia

author：hotspot 2025-08-12 06:43:18 - browse：6728

a liver made up by geometric shapes – biotech coverage from STAT — Adobe

LONDON — A drug in development as a weight loss treatment succeeded in a Phase 2 study in a serious liver condition, its developers said Monday, as the competition in the broader obesity medicine field pushes ahead.

The drug, survodutide, is being developed by the privately held German firm Boehringer Ingelheim and the Danish biotech Zealand Pharma. Zealand’s share price has doubled over the past year over the potential of the drug, and on Monday morning, shares jumped another 25%.

In the study, 83% of patients with a condition called MASH and who were treated with survodutide saw significant improvements in their disease compared to 18% of those who received placebo. The study met its primary endpoint of improvements in MASH after 48 weeks without the worsening of fibrosis, a scarring of the liver, the companies said. Secondary endpoints were also met, including an improvement in fibrosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Inside the rise of 'mukbang' eating videos

WSS

Bispecific antibodies are next new thing in cancer immunotherapy

State of the Union pitch: Bigger Medicare drug price negotiations

Xenotransplantation trials will require adjusting expectations, experts say

Xenotransplantation trials will require adjusting expectations, experts say

For AI in health care standards, federal regulators join with industry group

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

hotspot

Wikipedia

leisure time

Affirmative action in medical school literally saved lives

The untold story of TV’s first prescription drug ad

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Stem cell biologist probes earliest stages of human development

In Memoriam: Notable people who died in 2023

Fetal cell organoids grown from amniotic fluid, study finds

New air purifier tech could be key to improving indoor air quality

Longer MASH drug regimen improved liver, Akero study finds

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

knowledge

For AI in health care standards, federal regulators join with industry group

Fetal cell organoids grown from amniotic fluid, study finds

Immune cells and nerve overgrowth may explain recurring UTI pain

Biden administration plans revamp of organ transplant system

Harvard's David Sinclair gets blowback over aging

Lack of health data on LGBTQ+ people has serious consequences

explore

Wikipedia

leisure time

focus